Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Webinars from the Arcinova team

About this Event

This digital event was hosted by Arcinova and featured an industry case study and panel discussion, addressing the benefits of using the services of a contract development and manufacturing organisation to support the journey of your small molecule candidate through to clinic as swiftly, effectively and economically as possible.

This session was designed to provide you with a range of useful advice of what to consider and be aware of when choosing and working with a partner.  This will include factors such as: Location, speed, experience, technical expertise, capacity and agility.

After the panel discussion speakers were available to answer questions and provide practical advice in supporting company growth, overcoming barriers and problem solving, the recording also covers these discussions.

Format and panelists

The session was be moderated by Dr Nathalie Huther, Senior Director of Business Development, Europe at Arcinova, and the panelists included:
- Dr Gareth Jenkins, CSO at Arcinova
- Professor Chris Frampton, CEO of Rbar3 - a Chemistry, Solid-form and Crystallographic Consultancy service to the pharmaceutical and fine chemical industry sectors
- Dr Stephen Brown, Pharmaceutical Consultant and Advisor to a number of Biotech, CRO/CDMOs and technology companies involved in pharmaceutical product development.

Please click the image below to view the webinar

OBN Email